MRIGlobal director selected for Civic Council Kansas City Tomorrow Leadership Class
Dean Gray, Ph.D., Director of Intelligence, Surveillance and Reconnaissance at MRIGlobal, has been selected for…
MRIGlobal Vice President and General Counsel among Missouri Lawyers Media 2019 In-House Counsel Award Honorees
October 9, 2019 - MRIGlobal is pleased to announce that Reachel Beichley, J.D., has been…
North Kansas City Repository Celebrates 1,500th shipment for National Cancer Institute’s Division of Cancer Prevention
The crew at the Roger Harris Repository in North Kansas City, along with Principal Investigator…
Bill Nye The Science Guy among highlights of MRIGlobal 75th Anniversary Celebration
More than 500 civic leaders, community partners, science enthusiasts, clients, peers and friends gathered today…
First Phase of New Diagnostics Center of Excellence Opens
The first phase of a plan to establish a Diagnostics Center of Excellence at MRIGlobal’s…
Representative Emanuel Cleaver Honors MRIGlobal with Congressional Resolution
In honor of MRIGlobal’s 75th Anniversary, 5th Congressional District of Missouri U.S. Representative Emanuel Cleaver…
MRIGlobal plays key role in achieving FDA clearance for product to treat chemical weapon injuries
MRIGlobal client Argentum Medical achieved a milestone in its long-standing efforts to defend the country…
JPEO-CBRND Presents ISR Team with Awards for OASIS software system
Members of MRIGlobal's Intelligence, Surveillance, and Reconnaissance’s (ISR) software integration team received certificates of appreciation from…
MRIGlobal Presents Highest Honor to Four Trustees
MRIGlobal announces four Life Trustees. MRIGlobal’s highest honor was presented to Tom Bowser, Barrett Brady,…
Multiple Presentations at the First Global Health Security 2019 Conference In Sydney, Australia
MRIGlobal experts will present two talks as part of panel discussions and four posters at…
MRIGlobal Experts to Present Seven Posters and Co-Present a Breakout Session at the Association Of Public Health Laboratories (APHL) Annual Meeting
MRIGlobal experts have co-developed a breakout session on food safety and security and will also…
MRIGlobal Experts Have Nine Presentations on Genomic Sequencing at 14th Sequencing, Finishing, and Analysis in the Future (SFAF) Meeting
MRIGlobal experts will have nine presentations at the 14th Sequencing, Finishing, and Analysis in the…
ExxonMobil to Invest Up to $100 Million on Lower-Emissions R&D with U.S. National Labs
ExxonMobil said today it will invest up to $100 million over 10 years to research…
MRIGlobal Celebrates 30th Year at Society of Toxicology Annual Meeting
2019 Marks MRIGlobal’s 30th Year of Exhibiting at SOT MRIGlobal continued its annual presence at…
Enhancements Completed On U.S. Army’s State-of-the-Art Chemical Defense Training Facility (CDTF) at Fort Leonard Wood
CDTF to enhance personnel training that is central to the U.S. Department of Defense effort…
Chancellor of New Mexico State University/Director Emeritus of National Renewable Energy Laboratory Joins MRIGlobal Board of Directors
The MRIGlobal Board of Directors has elected Dan Arvizu, Ph.D., to join the Board of…
FIRST Robotics Team From Paseo Academy of Fine and Performing Arts ‘Blasts Off’ In Greater Kansas City Regional Competition
The FIRST Robotics season is in full swing for MRIGlobal’s Team 1763 from Paseo Academy…
MRIGlobal presented at 98th Annual Meeting of the Transportation Research Board
Four of MRIGlobal's Transportation Research Center staff participated in the 98th Annual Meeting of the…
MRIGlobal Scientists are Invited to India One Health Conference
MRIGlobal experts are in New Delhi participating in the launch of India’s new One Health…
MRIGlobal Leads Three Panel Discussions at ASM Biothreats, NDIA Specialty Conferences
MRIGlobal Experts Moderated Discussions Spanning Biodefense, Countering Weapons of Mass Destruction, Public-Private Partnerships MRIGlobal experts moderated…
MRIGlobal Hosts Open House on February 18 for Paseo’s FIRST Robotics Team
Open House for Paseo's FIRST Robotics Team MRIGlobal will host an open house from 3…
MRIGlobal to test system for Akonni Biosystems Device
Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx…
MRIGlobal Headlines 2019 American Society for Microbiology – Biothreats Conference
MRIGlobal will participate in the regular conference program as well as an industry and science…
Expanding In-Vitro Diagnostics and Research & Development Capabilities
MRIGlobal Presents Travel Awards at Central States Society of Toxicology Meeting
Best Paper Awards presented during the Central States Society of Toxicology Annual Meeting MRIGlobal is…
NREL Earns Two Prestigious R&D 100 Awards
MRIGlobal is pleased to announce that two innovations developed at the National Renewable Energy Laboratory…
Mercury Lab — A New Paradigm in Mobile Biosurveillance
The ability to extract biological information from a given environment has undergone substantial change in…
Board Appointments Bring In Key Expertise
MRIGlobal Board of Directors announces the election of three new members: Pam Berneking, Chief Commercial…
Renewed Contract for Chemopreventive Agent Repository
MRIGlobal has been awarded a 5-year, $19.9 million contract from the National Institutes of Health…
Risks of occupational exposure to Fentanyl – Podcasts
Join MRIGlobal’s Evan Durnal (Senior Chemist, Program and Technical Lead in Chemical Detection and Sampling/Co-founder…
Analytical Chemist Honored Among Ingram’s 40 Under Forty
MRIGlobal is pleased to announce Kristin Aillon, Ph.D., Program Manager and Principal Investigator, has been…
World War I Museum Features Panel Discussion on Chemical Warfare
As part of MRIGlobal’s support of The National World War I Museum’s special exhibition featuring…
Supporting the National WWI Museum Special Exhibit
MRIGlobal is proud to support The National World War I Museum’s special exhibition featuring John…
Continued Support for Shelf Life Evaluations
MRIGlobal continues support for shelf life evaluations of investigational dosage forms MRIGlobal today announced the…
MRIGlobal Supports Hispanic Organization of Toxicologists With Two Travel Awards
MRIGlobal is proud to announce the winners of its Hispanic Society of Toxicology Travel Awards.…
Travel Awards Presented at Central States Society of Toxicology Pave the Way for Research Presentations at Prestigious Toxicology Conference
Students receiving MRIGlobal travel awards at the Central States Society of Toxicology meeting last fall…
MRIGlobal Named Kansas City’s Healthiest Employer Two Years in a Row
MRIGlobal was named Healthiest Employer in Kansas City Business Journal’s Healthiest Employers competition (100-499…
MRIGlobal Immunologist Collaborates with UCLA in Published Study Showing Ebola Survivors May Have Lifetime Immunity
Kansas City, Mo. – Research from a UCLA Fielding School of Public Health study with…
MRIGlobal Supports Pre-Clinical Drug Development and Manufacture For National Institutes of Health National Center For Advancing Translational Sciences (NCATS)
MRIGlobal is supporting pre-clinical drug development for the National Institutes of Health (NIH) National Center…
HIGH CONTAINMENT FACILITY DEVELOPMENT
Large, complex integration programs are our forte. Our CBRNE and containment expertise spans decades and…
TESTING AND EVALUATION: CUTTING-EDGE TOOLS OF THE TRADE
The same technologies originally developed for monitoring chemical threat agents can be used to monitor…
MRIGLOBAL SUPPORTS PRE-CLINICAL DRUG DEVELOPMENT AND MANUFACTURE FOR NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)
Within NCATS, MRIGlobal Awarded “CRO Support for NCATS Drug Substance and Development” Kansas City, Mo.…
MRIGLOBAL PROVIDES BROAD RANGE OF SUPPORT TO THE U.S. DEPARTMENT OF DEFENSE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL AND BIOLOGICAL DEFENSE (JPEO-CBD)
A key task under the Homeland Defense Technical Area Tasks contract awarded to MRIGlobal will…
MRIGLOBAL SUPPORTS BARDA WITH DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIOLOGICAL THREATS
Biomedical Advanced Research and Development Authority (BARDA) Continues Relationship with MRIGlobal in Nonclincial Studies Network…
MRIGLOBAL WINS $13.7M NIH/NIAID QUALITY ASSESSMENT CONTRACT FOR MYCOBACTERIUM TUBERCULOSIS
MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and…
MRIGLOBAL WINS $13.7M NIH/NIAID QUALITY ASSESSMENT CONTRACT FOR MYCOBACTERIUM TUBERCULOSIS
MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and…
MRIGLOBAL’S DESIGN OF NEXT GENERATION MEDEVAC BIOCONTAINMENT SYSTEM WINS R&D MAGAZINE
MRIGlobal’s Containerized Bio Containment System (CBCS) wins R&D Magazine’s R&D 100 Award Kansas City,…
MRIGLOBAL, THERMO FISHER SCIENTIFIC, ARIZONA STATE UNIVERSITY LEAD TESTING OF DIAGNOSTIC MEDICAL COUNTERMEASURES PROGRAM FOR U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES’ OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS RESPONSE (ASPR)
ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide up to $100M over 10…
MRIGLOBAL FURTHERS STUDY OF ZIKA VIRUS INFECTION RESULTING IN MICROCEPHALY USING 2016 PATTON TRUST RESEARCH DEVELOPMENT GRANT
$50K Grant was awarded by The Kansas City Area Life Sciences Institute Kansas City, Mo.…
MRIGLOBAL LEADS INTERNATIONAL RESEARCH COLLABORATION FOR TULAREMIA VACCINE
Collaboration includes scientists from Canada, Sweden, U.S. in $6.2 million Defense Threat Reduction Agency contract…
WORLD’s LEADING, NEXT-GENERATION MEDEVAC BIOCONTAINMENT UNITS REVEALED
Partnership between U.S. State Department, and the Paul G. Allen Ebola Program, developed by MRIGlobal…
MRIGLOBAL LEADS STUDY AND PILOT PROJECT FOR REX INVESTMENT LIMITED TO ELECTRIFY RURAL TANZANIA
Funded by $818K (USD) Grant from US Trade and Development Agency, Project will use PV-Battery-Diesel…
MRIGLOBAL DEVELOPS WHOLE GENOME SEQUENCING DIAGNOSTIC SYSTEM
Sample-to-Sequence System has Potential to Revolutionize Clinical Diagnostics. Faster Diagnoses Result in Better Health Outcomes.…
MRIGLOBAL WINS $54 MILLION NIH NEUROLOGICAL DISORDERS AND STROKE CONTRACT TO SUPPORT DRUG DEVELOPMENT
National Institutes of Health Neurological Disorders and Stroke Contract Will Support Drug Manufacturing and ormulation…